Table 5.
Acylcarnitine profile of LT group: pre-LT and post-LT and of non-LT group
| LT(+) | Pre-LT | Post-LT | % | p |
| C3 | 14.41 ± 14.55 | 22.17 ± 8.71 | + 371.07% | 0.05 |
| C3:C2 | 2.046 ± 1.5673 | 0.9335 ± 0.3807 | −32.41% | 0.01* |
| MMA | 373.20 ± 1004.09 | 97.63 ± 63.19 | −79.99% | 0.15 |
| LT(−) | Initial | Latest | % | p compared with LT group |
| C3 | 11.18 ± 4.27 | 51.23 ± 51.07 | + 241.55% | 0.12 |
| C3:C2 | 0.8148 ± 0.27 | 1.1 ± 0.3920 | + 34.80% | *0.04 |
| MMA | 146.93 ± 433.87 | 109.39 ± 116.76 | −17.68% | 0.20 |
*indicated significant difference compared to false positive group (p < 0.05)
In LT(+) group: Pre-LT acylcarnitine level was collected 1 month before LT. Post-LT level was recruited at 4.1 ± 0.5 year after LT. In LT(−) group: Initial level indicates value at 1 month and latest values indicates at 3.9 ± 0.7 year